Sign In
Buy ARAY
$0.370
-0.0286 (-7.18%)
At Close: Jun 03, 2026
Accuray Reports Fiscal 2020 Third Quarter Financial Results
08:05pm, Tuesday, 28'th Apr 2020
Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2020 ended March 31, 2020.
IsoRay (NYSEAMERICAN:ISR) Upgraded to Buy by Zacks Investment Research
05:42am, Friday, 24'th Apr 2020
IsoRay (NYSEAMERICAN:ISR) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, Zacks.com reports. Th
New York, April 23, 2020 -- Reportlinker.com announces the release of the report "Global Surgical Robots Market - Premium Insight, Competitive News Feed Analysis, Company.
Bank of New York Mellon Corp Has $1.52 Million Stock Holdings in Accuray Incorporated (NASDAQ:ARAY)
09:02am, Thursday, 23'rd Apr 2020
Bank of New York Mellon Corp cut its stake in Accuray Incorporated (NASDAQ:ARAY) by 12.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Here's Why You Should Retain Accuray in Your Portfolio
12:27pm, Monday, 20'th Apr 2020
Investor confidence remains high in Accuray (ARAY) stock, thanks to solid prospects.
Here's Why You Should Retain Accuray in Your Portfolio
12:27pm, Monday, 20'th Apr 2020
Investor confidence remains high in Accuray (ARAY) stock, thanks to solid prospects.
Goldman Sachs Group Inc. Has $747,000 Holdings in Accuray Incorporated (NASDAQ:ARAY)
11:16am, Monday, 20'th Apr 2020
Goldman Sachs Group Inc. decreased its holdings in shares of Accuray Incorporated (NASDAQ:ARAY) by 43.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities
Varian Medical price target lowered to $90 from $100 at JPMorgan VAR;ARAY
01:25pm, Friday, 17'th Apr 2020
Varian Medical price target lowered to $90 from $100 at JPMorgan JPMorgan VAR ARAY
Accuray To Report Fiscal 2020 Third Quarter Financial Results on April 28, 2020
09:43pm, Thursday, 16'th Apr 2020
Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2020 on Tuesday, April 28, 2020 after the market close. Management will host a conference call to review t
IsoRay (NYSEAMERICAN:ISR) Rating Lowered to Hold at Zacks Investment Research
06:36am, Wednesday, 15'th Apr 2020
IsoRay (NYSEAMERICAN:ISR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “I
Veterinary Oncology Market Size Worth $447.0 Million by 2027: Grand View Research, Inc.
08:35am, Tuesday, 07'th Apr 2020
The global veterinary oncology market size is expected to reach USD 447.0 million by 2027, expanding at a CAGR of 10.7% over the forecast period, according to a new report by Grand View Research, Inc.
Comparing Glaukos (NYSE:GKOS) & Accuray (NYSE:ARAY)
09:34am, Tuesday, 31'st Mar 2020
Glaukos (NYSE:GKOS) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendat
Why You Should Invest in Cardinal Health (CAH) Stock Now
03:17pm, Monday, 30'th Mar 2020
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.
Why You Should Invest in Cardinal Health (CAH) Stock Now
03:17pm, Monday, 30'th Mar 2020
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.
